|
The Japanese journal of neuropsychology
|
|
Full Text of this Article
in Japanese PDF (107K)
|
ArticleTitle
|
Clinical features and neuropathological background of Lewy body disease; Parkinson's disease, Parkinson disease (with) dementia and dementia with Lewy bodies |
Language |
J |
AuthorList |
Shigeki Kuzuhara |
Affiliation |
Department of Neurology, Mie University Graduate School of Medicine |
Publication |
Japanese Journal of Neuropsychology: 22 (3), 200-211, 2006 |
Received |
|
Accepted |
|
Abstract |
Lewy body disease refers to a group of neurodegenerative diseases that are neuropathologically characterized by abundant Lewy bodies in the central nervous system. Lewy bodies and Lewy neurites are most sensitively demonstrated with α-synuclein immunohistochemistry. Three core clinical phenotypes include Parkinson's disease (PD), Parkinson disease (with) dementia (PDD) and dementia with Lewy bodies (DLB). As to the clinicopathological correlation, PD corresponds to the brainstem type, PDD, to the limbic type, and DLB, to the diffuse neocortical type of Lewy body disease. Full-blown clinical features as well as neuropathological findings are similar between PDD and DLB although the temporal sequence of appearance of parkinsonian symptoms and dementia are reversed between them. Recent gene studies have demonstrated that either mutation or increase in dose of the α-synuclein gene causes Lewy body disease, and the clinical phenotypes of PD, PDD and DLB may be related to the quality or quantity of the protein. Whether PDD and DLB are different clinical phenotypes of one disease or apparent resemblance of different diseases at the late stage remains to be clarified. |
Keywords |
Lewy body disease, dementia, Parkinson's disease, dementia with Lewy bodies, α-synucleis |
|